Literature DB >> 25572075

Pentylenetetrazol-induced seizure-like behavior and neural hyperactivity in the medicinal leech.

Elizabeth Hahn1, Brian Burrell.   

Abstract

This study examined the capacity of a known pro-epileptic drug, pentylenetetrazol (PTZ), to elicit seizure-like activity in the medicinal leech, Hirudo verbana. During in vivo experiments, PTZ elicited increased motor activity in a concentration-dependent manner with the highest concentration (10 mM) eliciting episodes of highly uncoordinated exploratory and swimming behavior. Co-application of the anti-epileptic drug, phenytoin, failed to reduce the absolute amount of PTZ-induced motor behavior, but was able to prevent expression of abnormal exploratory and swimming behaviors. During in vitro experiments in which extracellular recordings of connective nerve activity were made, bath application of 1 μM PTZ in Mg(2+)-free saline elicited a significant increase in spontaneous activity. This PTZ-induced increase in activity was completely inhibited by phenytoin. Interestingly, PTZ-induced hyperactivity was also blocked by co-application of the endocannabinoid 2-arachidonoyl glycerol and the selective serotonin re-uptake inhibitor (SSRI) fluoxetine. These findings suggest that the leech can be a useful system in which to study potential anti-epileptic treatments.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25572075     DOI: 10.1007/s10158-014-0177-1

Source DB:  PubMed          Journal:  Invert Neurosci        ISSN: 1354-2516


  48 in total

1.  Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain.

Authors:  Michael Iskedjian; Basil Bereza; Allan Gordon; Charles Piwko; Thomas R Einarson
Journal:  Curr Med Res Opin       Date:  2007-01       Impact factor: 2.580

2.  Associative, bidirectional changes in neural signaling utilizing NMDA receptor- and endocannabinoid-dependent mechanisms.

Authors:  Qin Li; Brian D Burrell
Journal:  Learn Mem       Date:  2011-08-15       Impact factor: 2.460

3.  CB1 and CB2 cannabinoid receptor expression during development and in epileptogenic developmental pathologies.

Authors:  E Zurolo; A M Iyer; W G M Spliet; P C Van Rijen; D Troost; J A Gorter; E Aronica
Journal:  Neuroscience       Date:  2010-07-13       Impact factor: 3.590

Review 4.  Molluscan memory of injury: evolutionary insights into chronic pain and neurological disorders.

Authors:  Edgar T Walters; Leonid L Moroz
Journal:  Brain Behav Evol       Date:  2009-12-21       Impact factor: 1.808

Review 5.  Seizure and epilepsy: studies of seizure disorders in Drosophila.

Authors:  Louise Parker; Iris C Howlett; Zeid M Rusan; Mark A Tanouye
Journal:  Int Rev Neurobiol       Date:  2011       Impact factor: 3.230

6.  Loss of interneuron LTD and attenuated pyramidal cell LTP in Trpv1 and Trpv3 KO mice.

Authors:  Travis E Brown; Anda M Chirila; Benjamin R Schrank; Julie A Kauer
Journal:  Hippocampus       Date:  2013-06-03       Impact factor: 3.899

7.  3H-GABA uptake selectively labels identifiable neurons in the leech central nervous system.

Authors:  H T Cline
Journal:  J Comp Neurol       Date:  1983-04-10       Impact factor: 3.215

Review 8.  Why do cannabinoid receptors have more than one endogenous ligand?

Authors:  Vincenzo Di Marzo; Luciano De Petrocellis
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-12-05       Impact factor: 6.237

9.  Mass-spectrometric identification of anandamide and 2-arachidonoylglycerol in nematodes.

Authors:  Marko Lehtonen; Kaja Reisner; Seppo Auriola; Garry Wong; James C Callaway
Journal:  Chem Biodivers       Date:  2008-11       Impact factor: 2.408

Review 10.  Endocannabinoid signaling as a synaptic circuit breaker in neurological disease.

Authors:  István Katona; Tamás F Freund
Journal:  Nat Med       Date:  2008-09-05       Impact factor: 53.440

View more
  1 in total

1.  A Systematic Review on Non-mammalian Models in Epilepsy Research.

Authors:  Muhammad Faiz Johan Arief; Brandon Kar Meng Choo; Jia Ling Yap; Yatinesh Kumari; Mohd Farooq Shaikh
Journal:  Front Pharmacol       Date:  2018-06-27       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.